Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121711) titled 'A Deep Learning-Radiomics Fusion Model Based on Super-Resolution Reconstruction Multimodal Ultrasound for Breast Cancer Neoadjuvant Chemotherapy Response Prediction' on April 1.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Condition:
Locally Advanced Breast Cancer
Intervention:
Gold Standard:Postoperative pathology: pathological complete response (pCR) defined as no residual invasive carcinoma in breast and axillary lymph nodes (ypT0/is ypN0), per Chinese Expert Consensus on Neoadjuvant Therapy for Breast Cancer (...